Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
national top stories
san francisco
4
×
startups
4
×
boston blog main
boston top stories
deals
life sciences
san francisco blog main
san francisco top stories
biotech
drugs
funding
innovation
medical devices
new york blog main
new york top stories
san diego blog main
san diego top stories
software
texas blog main
texas top stories
accelerator
acetylon pharmaceuticals
adha
airbnb
alafair bioscienes
alphabet
alto
amazon web services (aws)
ambys medicines
amyotrophic lateral sclerosis
apps
arlington
artificial intelligence (a.i.)
athelas
atomwise
austin
benchling
biotechnology
What
big
4
×
based
startup
tech
today
admits
ago
aiming
ambys
available
bio
biosciences
biotech
biotechs
candidate
cas
catch
cheaper
classes
combinator
companies
control
crispr
dallas
deadly
deal
debuted
delivery
develop
diagnostics
diseases
drug
dug
expects
faster
formed
future
incubator
innovation
latest
Language
unset
Current search:
big
×
startups
×
" san francisco "
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
5 years ago
Delivery Robots in Big D, Rodriguez Leaves the Station, & More TX Tech
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?